Due to increasingly effective treatment options for metastatic breast cancer and the long disease progression in the metastatic stage, a growing number of patients are suffering from cerebral metastases, especially in the HER2-positive breast cancer subgroup (Müller et al., 2025). The gene discussed is ERBB2; the disease is breast cancer.